Equillium, Inc. (LON:0A4D)
1.455
+0.237 (19.46%)
At close: Oct 17, 2025
Equillium Revenue
Equillium had revenue of $16.55 million USD in the twelve months ending June 30, 2025, down -61.16% year-over-year. In the year 2024, Equillium had annual revenue of $41.1 million with 13.89% growth.
Revenue (ttm)
$16.55M
Revenue Growth
-61.16%
P/S Ratio
5.37
Revenue / Employee
$472.94K
Employees
35
Market Cap
64.86M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 41.10M | 5.01M | 13.89% |
Dec 31, 2023 | 36.08M | 20.33M | 128.97% |
Dec 31, 2022 | 15.76M | - | - |
Dec 31, 2021 | - | - | - |
Dec 31, 2020 | - | - | - |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Shell | 198.54B |
BP p.l.c. | 134.89B |
Unilever | 51.24B |
AstraZeneca | 41.24B |
HSBC Holdings | 41.03B |
Rio Tinto Group | 39.22B |
GSK plc | 31.63B |
British American Tobacco p.l.c. | 25.60B |